Literature DB >> 28214090

Is intensity the solution for FMT in ulcerative colitis?

Britta Siegmund1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28214090     DOI： 10.1016/S0140-6736(17)30313-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  IBD in 2017: Development of therapy for and prediction of IBD - getting personal.

Authors:  Raja Atreya; Britta Siegmund
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-12-06       Impact factor: 46.802

Review 2.  Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation.

Authors:  Seong Ran Jeon; Jocelyn Chai; Christiana Kim; Christine H Lee
Journal:  Curr Infect Dis Rep       Date:  2018-05-26       Impact factor: 3.725

3.  Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment.

Authors:  Hans Herfarth; Edward L Barnes; Millie D Long; Kim L Isaacs; Tom Leith; Michael Silverstein; Ylaine Gerardin; Zain Kassam
Journal:  Inflamm Intest Dis       Date:  2019-03-29

Review 4.  Gut Microbiome Modulates Response to Cancer Immunotherapy.

Authors:  Md Abdul Wadud Khan; Gabriel Ologun; Reetakshi Arora; Jennifer L McQuade; Jennifer A Wargo
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

5.  Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea.

Authors:  Gi-Ung Kang; Sowon Park; Yeongyun Jung; Jai J Jee; Min-Sueng Kim; Seungjun Lee; Dong-Woo Lee; Jae-Ho Shin; Hong Koh
Journal:  Gut Liver       Date:  2022-08-17       Impact factor: 4.321

6.  Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series.

Authors:  Xiao-Fei Dang; Zhao Yin; Lin Sun; Wei-Hua Yang
Journal:  BMC Gastroenterol       Date:  2020-11-26       Impact factor: 3.067
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.